Q Therapeutics, Inc. 5
5 · Q Therapeutics, Inc. · Filed Feb 12, 2016
Insider Transaction Report
Form 5
Q Therapeutics, Inc.[NONE]
EPPSTEIN DEBORAH ANNE
CEO & President, Director
Transactions
- Award
Option to Purchase Common Stock
2015-09-09$0.70/sh+15,479$10,835→ 2,909,250 totalExercise: $0.70From: 2015-10-08Exp: 2025-09-08→ Common Stock (15,479 underlying)
Footnotes (1)
- [F1]All options were fully vested on December 31, 2015.